Article(id=1329527093471326973, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527047069741522, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.05.015, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1703433600000, receivedDateStr=2023-12-25, revisedDate=1707753600000, revisedDateStr=2024-02-13, acceptedDate=null, acceptedDateStr=null, onlineDate=1794913560502, onlineDateStr=2026-11-17, pubDate=1715270400000, pubDateStr=2024-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794913560502, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794913560502, creator=13701087609, updateTime=1794913560502, updator=13701087609, issue=Issue{id=1329527047069741522, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='5', pageStart='449', pageEnd='566', issueExtLink='null', onlineDate='null', pubDate='1715270400000', pubDateStr='2024-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794913549438, creator='13701087609', updateTime=1794962129197, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329730805833773281, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527047069741522, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329730805833773282, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329527047069741522, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=537, endPage=541, ext={EN=ArticleExt(id=1329527093748151042, articleId=1329527093471326973, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress of Bim protein in antitumor, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

B-cell lymphoma-2 cell death interaction regulator (Bim) is an important component of the B-cell lymphoma (Bcl)-2 family, and is the only protein in the Bcl-2 apoptosis protein family with a BH3 homologous domain. Bim can induce apoptosis by binding to apoptotic members in Bcl-2 through BH3 domain or directly activating pro-apoptotic molecules. The low expression of Bim protein is closely related to the development, prognosis and anti-tumor drug resistance of various tumors. Regulation of Bim protein expression has become a research hotspot. This article reviewed the research progress of Bim protein in antitumor.

, authors=Nan LI1, Jiyong MA2, *, authorsList=Nan LI, Jiyong MA, authorCompany=null, correspAuthors=Jiyong MA, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329527094050140932, articleId=1329527093471326973, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=Bim蛋白在抗肿瘤中的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

B细胞淋巴瘤-2细胞死亡相互作用调节子(B cell lymphoma-2 interacting mediator of cell death,Bim)是B细胞淋巴瘤(B cell lymphoma,Bcl)-2家族中的重要组成部分,也是Bcl-2凋亡蛋白家族中仅有一个BH3同源结构域的蛋白。Bim通过BH3结构域与Bcl-2中凋亡成员结合或直接活化促凋亡分子,诱导细胞凋亡。Bim蛋白的低表达与多种肿瘤的发生发展、预后及抗肿瘤药物的耐药性等密切相关。调控Bim蛋白表达已成为当前研究热点。该文将对Bim蛋白在抗肿瘤中的研究进展作综述。

, authors=李楠1, 马吉勇2, *, authorsList=李楠, 马吉勇, authorCompany=null, correspAuthors=马吉勇, authorNote=

李楠,硕士研究生,研究方向:肺部疾病诊治。

, correspAuthorsNote=
马吉勇,主任医师,研究方向:肺癌发生的分子机制。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=JxxxWUpnIEgWQdcJoqJEew==, magXml=sdkTeUPAYHjHB3JFm1NwmA==, pdfUrl=null, pdf=Tji6OPSpqkwRA6CvaE7DSg==, pdfFileSize=1566605, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=yrbPTqBpU+WCDzDoE1fotg==, mapNumber=null, fund=null)}, authors=[Author(id=1329527096524780300, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527096663192335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, authorId=1329527096524780300, language=EN, stringName=Nan LI, firstName=Nan, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.The Third Clinical School of Medicine, Nanjing Medical University, Nanjing 211166, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527096759661329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, authorId=1329527096524780300, language=CN, stringName=李楠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.南京医科大学第三临床医学院,江苏 南京 211166, bio={"content":"

李楠,硕士研究生,研究方向:肺部疾病诊治。

"}, bioImg=null, bioContent=

李楠,硕士研究生,研究方向:肺部疾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527094255661829, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, xref=1., ext=[AuthorCompanyExt(id=1329527094276633350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094255661829, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.The Third Clinical School of Medicine, Nanjing Medical University, Nanjing 211166, Jiangsu Province, China), AuthorCompanyExt(id=1329527094297604871, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094255661829, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.南京医科大学第三临床医学院,江苏 南京 211166)])]), Author(id=1329527096856130323, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329527096952599318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, authorId=1329527096856130323, language=EN, stringName=Jiyong MA, firstName=Jiyong, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Respiratory Medicine, Nanjing Hospital Affiliated to Nanjing Medical University, Nanjing 210006, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527097065845528, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, authorId=1329527096856130323, language=CN, stringName=马吉勇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.南京医科大学附属南京医院呼吸科,江苏 南京 210006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527094398268168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, xref=2., ext=[AuthorCompanyExt(id=1329527094406656777, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094398268168, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Respiratory Medicine, Nanjing Hospital Affiliated to Nanjing Medical University, Nanjing 210006, Jiangsu Province, China), AuthorCompanyExt(id=1329527094415045386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094398268168, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南京医科大学附属南京医院呼吸科,江苏 南京 210006)])])], keywords=[Keyword(id=1329527097170703129, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, language=EN, orderNo=1, keyword=B-cell lymphoma-2 interacting mediator of cell death protein), Keyword(id=1329527097279755035, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, language=EN, orderNo=2, keyword=apoptosis), Keyword(id=1329527097372029724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, language=EN, orderNo=3, keyword=antitumor), Keyword(id=1329527097447527198, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, language=CN, orderNo=1, keyword=B细胞淋巴瘤-2细胞死亡相互作用调节子蛋白), Keyword(id=1329527097531413279, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, language=CN, orderNo=2, keyword=细胞凋亡), Keyword(id=1329527097640465184, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, language=CN, orderNo=3, keyword=抗肿瘤)], refs=[Reference(id=1329527097816625953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of Bcl-2 family proteins[J]. Nat Rev Mol Cell Biol, 2019, 20(3): 175-193., articleTitle=null, refAbstract=null), Reference(id=1329527097908900642, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Cui Z, Feng R, Liu Z, et al. Receptor activator of nuclear factor (Nf)-κb ligand promotes T helper 17 cell differentiation through Fas[J]. Immunol Invest, 2022, 51(5): 1385-1397., articleTitle=null, refAbstract=null), Reference(id=1329527098001175331, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Green DR, Kroemer G. The pathophysiology of mitochondrial cell death[J]. Science, 2004, 305(5684): 626-629., articleTitle=null, refAbstract=null), Reference(id=1329527098110227237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Ladokhin AS. Regulation of apoptosis by the Bcl-2 family of proteins: field on a brink[J]. Cells, 2020, 9(9): 2121., articleTitle=null, refAbstract=null), Reference(id=1329527098202501927, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Hafezi S, Rahmani M. Targeting Bcl-2 in cancer: advances, challenges, and perspectives[J]. Cancers (Basel), 2021, 13(6): 1292., articleTitle=null, refAbstract=null), Reference(id=1329527098282193704, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Huang K, O'neill KL, Li J, et al. BH3-only proteins target Bcl-xL/Mcl-1, not BAX/BAK, to initiate apoptosis[J]. Cell Res, 2019, 29(11): 942-952., articleTitle=null, refAbstract=null), Reference(id=1329527098370274089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Sionov RV, Vlahopoulos SA, Granot Z. Regulation of Bim in health and disease[J]. Oncotarget, 2015, 6(27): 23058-23134., articleTitle=null, refAbstract=null), Reference(id=1329527098441577258, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Herold MJ, O'reilly LA, Lin A, et al. Evidence against upstream regulation of the unfolded protein response (UPR) by pro-apoptotic Bim and PUMA[J]. Cell Death Dis, 2014, 5(7): e1354., articleTitle=null, refAbstract=null), Reference(id=1329527098546434860, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Trotman LC, Alimonti A, Scaglioni PP, et al. Identification of a tumour suppressor network opposing nuclear Akt function[J]. Nature, 2006, 441(7092): 523-527., articleTitle=null, refAbstract=null), Reference(id=1329527098642903854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Heckmeier PJ, Ruf J, Janković BG, et al. Mcl-1 promiscuity and the structural resilience of its binding partners[J]. J Chem Phys, 2023, 158(9): 095101., articleTitle=null, refAbstract=null), Reference(id=1329527098730984240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Cai Z, Aguilera F, Ramdas B, et al. Targeting Bim via a lncRNA morrbid regulates the survival of preleukemic and leukemic cells[J]. Cell Rep, 2020, 31(12): 107816., articleTitle=null, refAbstract=null), Reference(id=1329527098823258929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Labi V, Peng S, Klironomos F, et al. Context-specific regulation of cell survival by a miRNA-controlled Bim rheostat[J]. Genes Dev, 2019, 33(23-24): 1673-1687., articleTitle=null, refAbstract=null), Reference(id=1329527098932310834, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Sur S, Steele R, Shi X, et al. miRNA-29b inhibits prostate tumor growth and induces apoptosis by increasing Bim expression[J]. Cells, 2019, 8(11): 1455., articleTitle=null, refAbstract=null), Reference(id=1329527100614226743, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Haftmann C, Stittrich AB, Zimmermann J, et al. miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim[J]. Eur J Immunol, 2015, 45(4): 1192-1205., articleTitle=null, refAbstract=null), Reference(id=1329527100735861560, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Kim J, Zhang Y, Skalski M, et al. microRNA-148a is a prognostic oncomiR that targets MIG6 and Bim to regulate EGFR and apoptosis in glioblastoma[J]. Cancer Res, 2014, 74(5): 1541-1553., articleTitle=null, refAbstract=null), Reference(id=1329527100823941946, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Sentana-Lledo D, Academia E, Viray H, et al. EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates[J]. Transl Lung Cancer Res, 2023, 12(7): 1590-1610., articleTitle=null, refAbstract=null), Reference(id=1329527100899439419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Ng KP, Hillmer AM, Chuah CT, et al. A common Bim deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer[J]. Nat Med, 2012, 18(4): 521-528., articleTitle=null, refAbstract=null), Reference(id=1329527100995908412, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhao W, Yu D, Chen Z, et al. Inhibition of MEK5/ERK5 signaling overcomes acquired resistance to the third generation EGFR inhibitor, osimertinib, via enhancing Bim-dependent apoptosis[J]. Cancer Lett, 2021, 519: 141-149., articleTitle=null, refAbstract=null), Reference(id=1329527101071405886, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanaka K, Yu HA, Yang S, et al. Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing Bim- and Puma-mediated apoptosis[J]. Cancer cell, 2021, 39(9): 1245-1261., articleTitle=null, refAbstract=null), Reference(id=1329527101167874880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Nie W, Tao X, Wei H, et al. The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: a systematic review and meta-analysis[J]. Oncotarget, 2015, 6(28): 25696-25700., articleTitle=null, refAbstract=null), Reference(id=1329527101243372353, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Li X, Zhang D, Li B, et al. Clinical implications of germline Bcl2L11 deletion polymorphism in pretreated advanced NSCLC patients with osimertinib therapy[J]. Lung Cancer, 2021, 151: 39-43., articleTitle=null, refAbstract=null), Reference(id=1329527101344035650, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanimoto A, Takeuchi S, Arai S, et al. Histone deacetylase 3 inhibition overcomes deletion polymorphism-mediated osimertinib resistance in EGFR-mutant lung cancer[J]. Clin Cancer Res, 2017, 23(12): 3139-3149., articleTitle=null, refAbstract=null), Reference(id=1329527101444698947, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=李玉倩. AD23协同组蛋白去乙酰化酶抑制剂抑制小细胞肺癌的作用及机制[D]. 石河子: 石河子大学, 2023., articleTitle=null, refAbstract=null), Reference(id=1329527101516002118, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Bhattacharya S, Piya S, Ma H, et al. Targeting unc51-like autophagy activating kinase 1 (ULK1) overcomes adaptive drug resistance in acute myelogenous leukemia[J]. Mol Cancer Res, 2023, 21(6): 548-563., articleTitle=null, refAbstract=null), Reference(id=1329527101591499591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=DiNardo CD, Jonas BA, Pullarkat V, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia[J]. N Engl J Med, 2020, 383(7): 617-629., articleTitle=null, refAbstract=null), Reference(id=1329527101675385672, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Le Gouill S, Morschhauser F, Chiron D, et al. Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial[J]. Blood, 2021, 137(7): 877-887., articleTitle=null, refAbstract=null), Reference(id=1329527101763466058, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Punnoose EA, Leverson JD, Peale F, et al. Expression Profile of Bcl-2, Bcl-xL, and Mcl-1 predicts pharmacological response to the Bcl-2 selective antagonist venetoclax in multiple myeloma models[J]. Mol Cancer Ther, 2016, 15(5): 1132-1144., articleTitle=null, refAbstract=null), Reference(id=1329527101910266700, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Hartman ML, Gajos-Michniewicz A, Talaj JA, et al. BH3 mimetics potentiate pro-apoptotic activity of encorafenib in BRAF melanoma cells[J]. Cancer Lett, 2021, 499: 122-136., articleTitle=null, refAbstract=null), Reference(id=1329527102010929997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Gambichler T, Rooms I, Scholl L, et al. BH3-only protein Bim predicts advanced stage of cutaneous melanoma[J]. J Eur Acad Dermatol Venereol, 2016, 30(11): 1926-1929., articleTitle=null, refAbstract=null), Reference(id=1329527102099010382, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Okamoto W, Okamoto I, Arao T, et al. Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification[J]. Mol Cancer Ther, 2012, 11(7): 1557-1564., articleTitle=null, refAbstract=null), Reference(id=1329527102195479375, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=张洪宇, 王伟, 张咏梅, 等. Bim基因多态性与HBV相关性肝癌预后的关系[J]. 中华医院感染学杂志, 2022, 32(1): 26-30., articleTitle=null, refAbstract=null), Reference(id=1329527102325502801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=李艳丽, 金建光, 周亚丽, 等. Bim和Otc4蛋白的表达对中晚期肾母细胞瘤患儿预后的评估价值[J]. 实用癌症杂志, 2021, 36(1): 53-56., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329527094255661829, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, xref=1., ext=[AuthorCompanyExt(id=1329527094276633350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094255661829, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.The Third Clinical School of Medicine, Nanjing Medical University, Nanjing 211166, Jiangsu Province, China), AuthorCompanyExt(id=1329527094297604871, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094255661829, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.南京医科大学第三临床医学院,江苏 南京 211166)]), AuthorCompany(id=1329527094398268168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, xref=2., ext=[AuthorCompanyExt(id=1329527094406656777, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094398268168, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Respiratory Medicine, Nanjing Hospital Affiliated to Nanjing Medical University, Nanjing 210006, Jiangsu Province, China), AuthorCompanyExt(id=1329527094415045386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094398268168, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南京医科大学附属南京医院呼吸科,江苏 南京 210006)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.05.015, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.05.015, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.05.015, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.05.015, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1715270400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
Bim蛋白在抗肿瘤中的研究进展
李楠 1 , 马吉勇 2, *
世界临床药物 | 综述评论 2024,45(5): 537-541
收起
收藏切换
世界临床药物 |综述评论 2024 , 45 (5) : 537 -541
Bim蛋白在抗肿瘤中的研究进展
全屏
[Author(id=1329527096524780300, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329527096663192335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, authorId=1329527096524780300, language=EN, stringName=Nan LI, firstName=Nan, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.The Third Clinical School of Medicine, Nanjing Medical University, Nanjing 211166, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527096759661329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, authorId=1329527096524780300, language=CN, stringName=李楠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.南京医科大学第三临床医学院,江苏 南京 211166, bio={"content":"

李楠,硕士研究生,研究方向:肺部疾病诊治。

"}, bioImg=null, bioContent=

李楠,硕士研究生,研究方向:肺部疾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527094255661829, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, xref=1., ext=[AuthorCompanyExt(id=1329527094276633350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094255661829, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.The Third Clinical School of Medicine, Nanjing Medical University, Nanjing 211166, Jiangsu Province, China), AuthorCompanyExt(id=1329527094297604871, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094255661829, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.南京医科大学第三临床医学院,江苏 南京 211166)])]), Author(id=1329527096856130323, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329527096952599318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, authorId=1329527096856130323, language=EN, stringName=Jiyong MA, firstName=Jiyong, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Respiratory Medicine, Nanjing Hospital Affiliated to Nanjing Medical University, Nanjing 210006, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329527097065845528, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, authorId=1329527096856130323, language=CN, stringName=马吉勇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.南京医科大学附属南京医院呼吸科,江苏 南京 210006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329527094398268168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, xref=2., ext=[AuthorCompanyExt(id=1329527094406656777, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094398268168, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Respiratory Medicine, Nanjing Hospital Affiliated to Nanjing Medical University, Nanjing 210006, Jiangsu Province, China), AuthorCompanyExt(id=1329527094415045386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329527093471326973, companyId=1329527094398268168, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.南京医科大学附属南京医院呼吸科,江苏 南京 210006)])])]
李楠1, 马吉勇2, *
作者信息
  • 1.南京医科大学第三临床医学院,江苏 南京 211166
  • 2.南京医科大学附属南京医院呼吸科,江苏 南京 210006
通讯作者:
马吉勇,主任医师,研究方向:肺癌发生的分子机制。
作者简介:

李楠,硕士研究生,研究方向:肺部疾病诊治。

Research progress of Bim protein in antitumor
Nan LI1, Jiyong MA2, *
Affiliations
  • 1.The Third Clinical School of Medicine, Nanjing Medical University, Nanjing 211166, Jiangsu Province, China
  • 2.Department of Respiratory Medicine, Nanjing Hospital Affiliated to Nanjing Medical University, Nanjing 210006, Jiangsu Province, China
出版时间: 2024-05-10 doi: 10.13683/j.wph.2024.05.015
文章导航
收藏切换

B细胞淋巴瘤-2细胞死亡相互作用调节子(B cell lymphoma-2 interacting mediator of cell death,Bim)是B细胞淋巴瘤(B cell lymphoma,Bcl)-2家族中的重要组成部分,也是Bcl-2凋亡蛋白家族中仅有一个BH3同源结构域的蛋白。Bim通过BH3结构域与Bcl-2中凋亡成员结合或直接活化促凋亡分子,诱导细胞凋亡。Bim蛋白的低表达与多种肿瘤的发生发展、预后及抗肿瘤药物的耐药性等密切相关。调控Bim蛋白表达已成为当前研究热点。该文将对Bim蛋白在抗肿瘤中的研究进展作综述。

B细胞淋巴瘤-2细胞死亡相互作用调节子蛋白  /  细胞凋亡  /  抗肿瘤

B-cell lymphoma-2 cell death interaction regulator (Bim) is an important component of the B-cell lymphoma (Bcl)-2 family, and is the only protein in the Bcl-2 apoptosis protein family with a BH3 homologous domain. Bim can induce apoptosis by binding to apoptotic members in Bcl-2 through BH3 domain or directly activating pro-apoptotic molecules. The low expression of Bim protein is closely related to the development, prognosis and anti-tumor drug resistance of various tumors. Regulation of Bim protein expression has become a research hotspot. This article reviewed the research progress of Bim protein in antitumor.

B-cell lymphoma-2 interacting mediator of cell death protein  /  apoptosis  /  antitumor
李楠, 马吉勇. Bim蛋白在抗肿瘤中的研究进展. 世界临床药物, 2024 , 45 (5) : 537 -541 . DOI: 10.13683/j.wph.2024.05.015
Nan LI, Jiyong MA. Research progress of Bim protein in antitumor[J]. World Clinical Drug, 2024 , 45 (5) : 537 -541 . DOI: 10.13683/j.wph.2024.05.015

参考文献 引证文献
排序方式:
[1]
Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of Bcl-2 family proteins[J]. Nat Rev Mol Cell Biol, 2019, 20(3): 175-193.
[2]
Cui Z, Feng R, Liu Z, et al. Receptor activator of nuclear factor (Nf)-κb ligand promotes T helper 17 cell differentiation through Fas[J]. Immunol Invest, 2022, 51(5): 1385-1397.
[3]
Green DR, Kroemer G. The pathophysiology of mitochondrial cell death[J]. Science, 2004, 305(5684): 626-629.
[4]
Ladokhin AS. Regulation of apoptosis by the Bcl-2 family of proteins: field on a brink[J]. Cells, 2020, 9(9): 2121.
[5]
Hafezi S, Rahmani M. Targeting Bcl-2 in cancer: advances, challenges, and perspectives[J]. Cancers (Basel), 2021, 13(6): 1292.
[6]
Huang K, O'neill KL, Li J, et al. BH3-only proteins target Bcl-xL/Mcl-1, not BAX/BAK, to initiate apoptosis[J]. Cell Res, 2019, 29(11): 942-952.
[7]
Sionov RV, Vlahopoulos SA, Granot Z. Regulation of Bim in health and disease[J]. Oncotarget, 2015, 6(27): 23058-23134.
[8]
Herold MJ, O'reilly LA, Lin A, et al. Evidence against upstream regulation of the unfolded protein response (UPR) by pro-apoptotic Bim and PUMA[J]. Cell Death Dis, 2014, 5(7): e1354.
[9]
Trotman LC, Alimonti A, Scaglioni PP, et al. Identification of a tumour suppressor network opposing nuclear Akt function[J]. Nature, 2006, 441(7092): 523-527.
[10]
Heckmeier PJ, Ruf J, Janković BG, et al. Mcl-1 promiscuity and the structural resilience of its binding partners[J]. J Chem Phys, 2023, 158(9): 095101.
[11]
Cai Z, Aguilera F, Ramdas B, et al. Targeting Bim via a lncRNA morrbid regulates the survival of preleukemic and leukemic cells[J]. Cell Rep, 2020, 31(12): 107816.
[12]
Labi V, Peng S, Klironomos F, et al. Context-specific regulation of cell survival by a miRNA-controlled Bim rheostat[J]. Genes Dev, 2019, 33(23-24): 1673-1687.
[13]
Sur S, Steele R, Shi X, et al. miRNA-29b inhibits prostate tumor growth and induces apoptosis by increasing Bim expression[J]. Cells, 2019, 8(11): 1455.
[14]
Haftmann C, Stittrich AB, Zimmermann J, et al. miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim[J]. Eur J Immunol, 2015, 45(4): 1192-1205.
[15]
Kim J, Zhang Y, Skalski M, et al. microRNA-148a is a prognostic oncomiR that targets MIG6 and Bim to regulate EGFR and apoptosis in glioblastoma[J]. Cancer Res, 2014, 74(5): 1541-1553.
[16]
Sentana-Lledo D, Academia E, Viray H, et al. EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates[J]. Transl Lung Cancer Res, 2023, 12(7): 1590-1610.
[17]
Ng KP, Hillmer AM, Chuah CT, et al. A common Bim deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer[J]. Nat Med, 2012, 18(4): 521-528.
[18]
Zhao W, Yu D, Chen Z, et al. Inhibition of MEK5/ERK5 signaling overcomes acquired resistance to the third generation EGFR inhibitor, osimertinib, via enhancing Bim-dependent apoptosis[J]. Cancer Lett, 2021, 519: 141-149.
[19]
Tanaka K, Yu HA, Yang S, et al. Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing Bim- and Puma-mediated apoptosis[J]. Cancer cell, 2021, 39(9): 1245-1261.
[20]
Nie W, Tao X, Wei H, et al. The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: a systematic review and meta-analysis[J]. Oncotarget, 2015, 6(28): 25696-25700.
[21]
Li X, Zhang D, Li B, et al. Clinical implications of germline Bcl2L11 deletion polymorphism in pretreated advanced NSCLC patients with osimertinib therapy[J]. Lung Cancer, 2021, 151: 39-43.
[22]
Tanimoto A, Takeuchi S, Arai S, et al. Histone deacetylase 3 inhibition overcomes deletion polymorphism-mediated osimertinib resistance in EGFR-mutant lung cancer[J]. Clin Cancer Res, 2017, 23(12): 3139-3149.
[23]
李玉倩. AD23协同组蛋白去乙酰化酶抑制剂抑制小细胞肺癌的作用及机制[D]. 石河子: 石河子大学, 2023.
[24]
Bhattacharya S, Piya S, Ma H, et al. Targeting unc51-like autophagy activating kinase 1 (ULK1) overcomes adaptive drug resistance in acute myelogenous leukemia[J]. Mol Cancer Res, 2023, 21(6): 548-563.
[25]
DiNardo CD, Jonas BA, Pullarkat V, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia[J]. N Engl J Med, 2020, 383(7): 617-629.
[26]
Le Gouill S, Morschhauser F, Chiron D, et al. Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial[J]. Blood, 2021, 137(7): 877-887.
[27]
Punnoose EA, Leverson JD, Peale F, et al. Expression Profile of Bcl-2, Bcl-xL, and Mcl-1 predicts pharmacological response to the Bcl-2 selective antagonist venetoclax in multiple myeloma models[J]. Mol Cancer Ther, 2016, 15(5): 1132-1144.
[28]
Hartman ML, Gajos-Michniewicz A, Talaj JA, et al. BH3 mimetics potentiate pro-apoptotic activity of encorafenib in BRAF melanoma cells[J]. Cancer Lett, 2021, 499: 122-136.
[29]
Gambichler T, Rooms I, Scholl L, et al. BH3-only protein Bim predicts advanced stage of cutaneous melanoma[J]. J Eur Acad Dermatol Venereol, 2016, 30(11): 1926-1929.
[30]
Okamoto W, Okamoto I, Arao T, et al. Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification[J]. Mol Cancer Ther, 2012, 11(7): 1557-1564.
[31]
张洪宇, 王伟, 张咏梅, 等. Bim基因多态性与HBV相关性肝癌预后的关系[J]. 中华医院感染学杂志, 2022, 32(1): 26-30.
[32]
李艳丽, 金建光, 周亚丽, 等. Bim和Otc4蛋白的表达对中晚期肾母细胞瘤患儿预后的评估价值[J]. 实用癌症杂志, 2021, 36(1): 53-56.
2024年第45卷第5期
16
1
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.05.015
  • 接收时间:2023-12-25
  • 首发时间:2026-11-17
  • 出版时间:2024-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-12-25
  • 修回日期:2024-02-13
基金
作者信息
    1.南京医科大学第三临床医学院,江苏 南京 211166
    2.南京医科大学附属南京医院呼吸科,江苏 南京 210006

通讯作者:

马吉勇,主任医师,研究方向:肺癌发生的分子机制。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.05.015
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏